Research Article
Plasma C1q/TNF-Related Protein-3 (CTRP-3) and High-Mobility Group Box-1 (HMGB-1) Concentrations in Subjects with Prediabetes and Type 2 Diabetes
Table 2
Spearman and partial correlation analyses between variables and plasma CTRP-3 and HMGB-1.
| | Plasma CTRP-3 | Plasma CTRP-3 (age- and sex-adjusted) | Plasma HMGB-1 | Plasma HMGB-1 (age- and sex-adjusted) | | | | | | | | | |
| Age (years) | −0.152 | 0.021 | | | 0.106 | 0.111 | | | FPG (mmol/L) | −0.745 | <0.001 | −0.756 | <0.001 | 0.615 | <0.001 | 0.61 | <0.001 | INS | −0.635 | <0.001 | −0.626 | <0.001 | 0.604 | <0.001 | 0.529 | <0.001 | HOMA-IR | −0.763 | <0.001 | −0.756 | <0.001 | 0.693 | <0.001 | 0.689 | <0.001 | 2 h PG (mmol/L) | −0.67 | <0.001 | −0.66 | <0.001 | 0.61 | <0.001 | 0.604 | <0.001 | HbA1c (%) | −0.806 | <0.001 | −0.802 | <0.001 | 0.677 | <0.001 | 0.674 | <0.001 | BMI (kg/m2) | −0.219 | 0.001 | −0.202 | 0.002 | 0.216 | 0.001 | 0.203 | 0.002 | WHR | −0.374 | <0.001 | −0.357 | <0.001 | 0.255 | <0.001 | 0.242 | <0.001 | SBP (mmHg) | −0.089 | 0.181 | −0.085 | 0.202 | 0.129 | 0.052 | 0.124 | 0.062 | DBP (mmHg) | −0.14 | 0.034 | −0.127 | 0.054 | 0.124 | 0.061 | 0.087 | 0.108 | TC (mmol/L) | −0.094 | 0.154 | −0.095 | 0.156 | 0.033 | 0.624 | 0.032 | 0.145 | TG (mmol/L) | −0.213 | 0.001 | −0.188 | 0.004 | 0.163 | 0.014 | 0.145 | 0.029 | LDL-C (mmol/L) | −0.152 | 0.021 | −0.142 | 0.032 | 0.25 | <0.001 | 0.243 | <0.001 | HDL-C (mmol/L) | 0.369 | <0.001 | 0.372 | <0.001 | −0.403 | <0.001 | −0.405 | <0.001 | ALT (U/L) | −0.02 | 0.769 | −0.014 | 0.829 | 0.022 | 0.736 | 0.02 | 0.77 | AST (U/L) | −0.07 | 0.292 | −0.064 | 0.342 | 0.024 | 0.722 | 0.019 | 0.772 | γ-GGT (U/L) | −0.124 | 0.032 | −0.115 | 0.051 | 0.136 | 0.027 | 0.085 | 0.114 | Cr | −0.056 | 0.4 | −0.055 | 0.41 | 0.066 | 0.324 | 0.067 | 0.319 | IL-6 (pg/mL) | −0.797 | <0.001 | −0.781 | <0.001 | 0.696 | <0.001 | 0.695 | <0.001 |
|
|
Correlations between variables were analyzed by Spearman’s correlation test and age- and sex-adjusted partial correlation test. CTRP-3, C1q/TNF-related protein-3; HMGB-1, high-mobility group box-1; FPG, fasting plasma glucose; FINS, fasting serum insulin; HOMA-IR, homeostasis model assessment for insulin resistance; 2 h PG, 2 h postchallenge plasma glucose; HbA1c, hemoglobin A1c; BMI, body mass index; WHR, waist-to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; AST, aspartate transaminase; ALT, alanine transaminase; γ-GGT, gamma-glutamyl transpeptidase; IL-6, interleukin-6.
|